What is Epicrop Technologies?
Epicrop Technologies specializes in epigenetic crop breeding, employing a nature-based methodology to improve crop yields and resilience. Their proprietary technologies integrate epigenetic variation with computational science to optimize crop selection, leading to notable increases in yield and the development of traits such as heat and cold tolerance. The company is strategically positioned to address the needs of agricultural sectors seeking sustainable advancements to bolster crop quality in the face of evolving climate challenges. With over a decade of rigorous field trials, EpiCrop Technologies is prepared to introduce its innovative, non-GMO technology to the commercial market, offering a distinct advantage in agricultural productivity.
How much funding has Epicrop Technologies raised?
Epicrop Technologies has raised a total of $3.3M across 2 funding rounds:
Series A
$3.2M
Debt
$116K
Series A (2017): $3.2M with participation from Nelnet, Inc., TechAccel, Speedway Properties, and Allen & Company
Debt (2021): $116K led by PPP
Key Investors in Epicrop Technologies
TechAccel
TechAccel is a venture development organization focused on commercializing innovations in agriculture, animal health, and food technology. They invest capital and research expertise to advance sustainable food production and quality, often collaborating with startups and universities.
Nelnet, Inc.
Nelnet, Inc. is a diversified financial services company that also provides payment technology for educational institutions and internet services. Their investment in Epicrop Technologies suggests an interest in innovative agricultural technology.
Speedway Properties
Speedway Properties is a real estate company specializing in commercial and residential properties, primarily in Lincoln, Nebraska. Their participation in this funding round indicates a diversified investment strategy.
What's next for Epicrop Technologies?
The substantial enterprise-level funding and recent strategic investment signal a pivotal growth phase for Epicrop Technologies. This capital infusion is expected to accelerate the commercialization of their epigenetic crop breeding technology, enabling broader market penetration and further research and development. The company's focus on sustainable, non-GMO solutions aligns with global agricultural trends, positioning it for significant expansion. Future endeavors will likely involve scaling production, forging new partnerships, and continuing to innovate in crop enhancement to meet the increasing demands for resilient and high-yielding crops.
See full Epicrop Technologies company page
